Medtronic (MDT) Q2 Earnings and Revenues Top Estimates

Company Performance - Medtronic reported quarterly earnings of $1.36 per share, exceeding the Zacks Consensus Estimate of $1.31 per share, and up from $1.26 per share a year ago, representing an earnings surprise of +3.82% [1] - The company posted revenues of $8.96 billion for the quarter ended October 2025, surpassing the Zacks Consensus Estimate by 1.11%, compared to $8.4 billion in the same quarter last year [2] - Medtronic has surpassed consensus EPS estimates in all four of the last quarters and topped consensus revenue estimates three times during the same period [2] Stock Performance - Medtronic shares have increased approximately 20.5% since the beginning of the year, outperforming the S&P 500's gain of 13.4% [3] - The current consensus EPS estimate for the upcoming quarter is $1.35 on revenues of $8.83 billion, and for the current fiscal year, it is $5.63 on revenues of $35.8 billion [7] Industry Outlook - The Medical - Products industry, to which Medtronic belongs, is currently ranked in the bottom 30% of over 250 Zacks industries, indicating potential challenges ahead [8] - The performance of Medtronic's stock may be influenced by the overall outlook for the industry, as research shows that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]